Authors:
Nicholson, KG
Colegate, AE
Podda, A
Stephenson, I
Wood, J
Ypma, E
Zambon, MC
Citation: Kg. Nicholson et al., Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza, LANCET, 357(9272), 2001, pp. 1937-1943
Citation: Kg. Nicholson, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial (vol 355, pg 1845, 2000), LANCET, 356(9244), 2000, pp. 1856-1856
Authors:
Nicholson, KG
Aoki, FY
Osterhaus, ADME
Trottier, S
Carewicz, O
Mercier, CH
Rode, A
Kinnersley, N
Ward, P
Citation: Kg. Nicholson et al., Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, LANCET, 355(9218), 2000, pp. 1845-1850
Citation: Kg. Nicholson et al., Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination, EPIDEM INFE, 123(1), 1999, pp. 103-108
Authors:
Wiselka, MJ
Nicholson, KG
Rowley, S
Bibby, K
Citation: Mj. Wiselka et al., Cytomegalovirus viraemia has poor predictive value for the development of cytomegalovirus disease in patients with advanced HIV-infection, J INFECTION, 39(3), 1999, pp. 187-192